Clinical Trial Safety

Cell & Gene Therapy

[Video] Institutional Biosafety Committee Review: Strategies to Secure Rapid IBC Approval for Human Gene Transfer Trials

Clinical Endpoints

Relieving the Safety Reporting Burden on Sites: 4 Takeaways

Two colleagues submit their study for IRB review on WCG IRB Connexus, streamlining their protocol review.

Clinical Endpoints

See How WCG Helped a Mid-tier Biopharma Respond to an Urgent FDA Request, and Adjudicated 400 Endpoints in Just a Few Short Weeks

Clinical Endpoints

The Burden of Safety Reporting on Sites: An Oncology Site’s Perspective

Cell & Gene Therapy

Four Key Elements You Need to Know About the Role of IBCs in Gene Therapy Trials

Cell & Gene Therapy

As a sponsor, does my HGT clinical trial require IBC approval at all sites?

Cell & Gene Therapy

Does Human Gene Transfer research at my site require IBC approval?

Clinical Trial Safety

What are IRB submission requirements for post marketing safety reports?

Clinical Endpoints

How WCG Statistics Collaborative Helped Breakthrough Therapy Obtain Regulatory Approval

Clinical Trial Safety

Submitting Deviations from a Sponsor’s Adverse Event Reporting Requirements to the IRB

Webinar Series: Overcoming Obstacles – Addressing Key Site Challenges Now & Into the Future

November 5, 2025 - December 10, 2025 @ 11:00AM EST @ Webinar Series

Join WCG for an in-depth exploration of the most pressing challenges facing clinical research sites today. This 3-part webinar series… Event Details